Uninsured risks
Whether you have a high street pharmacy or a dispensary in a health centre, most leases require the landlord to insure the building. This obligation usually covers risks such as fire, lightening and flood. If the pharmacy is damaged or destroyed by one of these risks, the lease explains who is responsible for repairing the damage and who pays the cost.
However, some leases don’t deal with what happens if the pharmacy is damaged or destroyed by a risk that isn’t covered by insurance (“an uninsured risk”). Terrorism is often quoted as a risk that isn’t covered by insurance. However insurers are increasingly withdrawing flood risk from their insurance policies, following the recent disasters seen across the country.
Who is to Repair?
The pharmacist is responsible for repairing the whole of the property let to them. Most repair obligations are limited to exclude damage by a risk that the landlord has insured against. However they often don’t deal with what happens if the property is damaged or destroyed by a risk that the landlord has not insured against. This could be due to an exclusion or limitation in the policy, or because insurance is simply not available.
If the pharmacists repair liability isn’t limited, they will remain responsible for the cost of, and the carrying out of, any repair or reinstatement works required. Where the lease is a lease of part of the landlord’s building, such as a pharmacy within a health centre, the landlord is likely to be able to recover their costs of repairing the structure of the building where damaged or destroyed by a risk they have not insured against through the service charge.
What if the Pharmacy cannot be used?
If the pharmacy can not be used due to damage by a risk that is not covered by insurance, the pharmacist may not only find themselves responsible for the cost of repairing any such damage caused, but may also remain responsible for paying the rent for the pharmacy during the period that the property cannot be used because of the damage caused.
What to do about Uninsured Risks?
Uninsured risks need to be considered when pharmacists are looking to buy an existing lease, take a new lease or renew an existing lease. In the current climate most commercial landlords are alert to the difficulties caused by uninsured risks and are willing to agree something with the pharmacist to make it clear exactly happens if the pharmacy is damaged by one of these risks. However it will often depend on the bargaining power of each party as to whether the pharmacist can shift the responsibility for uninsured risks onto the landlord.
Repair: Landlord’s will often agree that pharmacists will not be responsible for the cost of repairing any damage caused to the pharmacy by a risk that is not covered by insurance (unless the pharmacist has stopped the insurance from being available). This should be an exclusion from the repair responsibility in the lease, as well as an exclusion from the service charge, so that there is no way of the landlord sneaking the cost from the pharmacist unknowingly. The pharmacist will however remain responsible for any damage caused to their own contents or fixtures and fittings.
Rent: Most commercial leases allow for a suspension of rent if the pharmacy cannot be used following damage. This suspension of rent should also apply where the damage has been caused by an uninsured risk.
Reinstatement: Once the rent has been suspended and the pharmacist is not incurring any cost, it is up to the landlord to decide whether they want to repair the pharmacy. If they do want to repair, any repair works should be at their own cost. However if the landlord is paying to repair the damage, they are likely to want to make sure they still have a tenant once the works have been completed, so there is still someone in situ to pay the rent. It is therefore often agreed that the landlord will have a certain period to decide whether they want to reinstate and the pharmacist will not be able to terminate the lease until this decision has been made. If the landlord does decide to reinstate, they will again have an agreed period within which to carry out these works. If the works are not carried out by the end of the agreed period so that the pharmacy can once again be used, the pharmacist ought to have the opportunity to terminate the lease and move to alternative premises.
In order to retain continuity of services, depending on the extent of the damage, the pharmacist may need to make alternative arrangements to continue trading whilst the pharmacy cannot be used. It is therefore important to make sure that they don’t have to pay rent for two properties during this period, are not responsible for exorbitant repair costs and that the timer periods for works to take place are appropriate and agreed for the relevant situation.
For more information please contact Tim Jenkins on +44 (0)1483 252529 or tim.jenkins@crsblaw.com
Our thinking
Sara Wilson
Sleep-in workers not entitled to NMW for entire shift
A unanimous ruling by The Supreme Court in the Royal Mencap v Tomlinson-Blake and another case.
Amelia Goodwin
Amelia Goodwin quoted by People Management, Home Care Insight and Care Home Management on the implications of the Supreme Court's ruling in Royal Mencap Society v Tomlinson-Blake
The court found that care providers do not have to pay the minimum wage to staff for time that they are asleep but on call during shifts.
Noel Wardle
Pharmacy Brief - March 2021
The March edition of our Pharmacy Brief
Jonathan Steele
The firm's role in advising Dentex on the acquisition of The Essex Smile Centre reported by Business Money
The sale of The Essex Smile Centre to Dentex Healthcare Group Limited has been completed.
Natalie Deuchar
Natalie Deuchar and Leonora Owens write for Pharmacy Business on the considerations to take into account when pharmacists look to obtain a new unit
Pharmacists should be aware of the law when considering obtaining a new unit.
Noel Wardle
Noel Wardle quoted by Chemist and Druggist on the issues that need to be considered before pharmacies adopt a hub-and-spoke dispensing model
Under current legislation, the hub-and-spoke model can be carried out by pharmacies owned by the same legal entity.
Noel Wardle
Noel Wardle writes for Chemist and Druggist on whether pharmacy professionals can be sued for COVID vaccine negligence
Rebecca Burford
Charles Russell Speechlys' Corporate team shortlisted for the 2021 South East Dealmakers Awards
Our Guildford team shortlisted at the Insider South East Dealmakers Awards 2021 for Corporate Law Firm of the Year.
Noel Wardle
Pharmacy Brief - December 2020
The December edition of our Pharmacy Brief
William Nash
Charles Russell Speechlys advises Emergex Vaccines on $11m fundraising
Emergex is a UK-based biotechnology company and pioneers of developing synthetic ‘set point’ vaccines .
Mark Howard
Public Company Update - November 2020
The November 2020 edition of our biannual Public Company Update.
Noel Wardle
Noel Wardle writes for Chemist and Druggist on how pharmacists can supply the COVID-19 vaccine lawfully
Helen Wong
Charles Russell Speechlys advises on sale of dental practice Feltham Dental
Feltham Dental was established in 1982, the business is an integral part of the community and has many generations of loyal patients.
Pei-Li Kew writes for P3 Pharmacy on the differences between share and asset transactions when buying a pharmacy
Noel Wardle writes for Pharmacy Business on whether a notice to close a pharmacy can be withdrawn
Michael Lingens
Charles Russell Speechlys advises CareTech on the acquisition of Smartbox
Smartbox is a market-leading creator of software and hardware that helps disabled people without speech to live more independently.
Hamish Perry
Charles Russell Speechlys advises Wimbledon NeuroCare and Ascot Rehabilitation on the acquisition of a healthcare diagnostic centre
Both Ascot Rehab and Wimbledon NeuroCare provide high quality rehabilitation services for people with neurological conditions.
Noel Wardle writes for Chemist & Druggist on the downsides of the new MUR legislation
Ayman Shehata
High Stakes
On 18 September, the FCA set out its approach in assessing applications by cannabis-related companies for listing in the UK.
Noel Wardle
Pharmacy Brief - September 2020
The September edition of our Pharmacy Brief